Michihito Sasaki

Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant

Rigel Suzuki, Daichi Yamasoba, Izumi Kimura et al. · Nature · 2022 · 749 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +9

Discovery of S-217622, a Noncovalent Oral SARS-CoV-2 3CL Protease Inhibitor Clinical Candidate for Treating COVID-19

Yuto Unoh, Shota Uehara, Kenji Nakahara et al. · Journal of Medicinal Chemistry · 2022 · 590 citations · Full text

Medicine, Infectious Diseases, Pharmacology +15

Virological characteristics of the SARS-CoV-2 Omicron BA.2 spike

Daichi Yamasoba, Izumi Kimura, Hesham Nasser et al. · Cell · 2022 · 348 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +15

RIG-I triggers a signaling-abortive anti-SARS-CoV-2 defense in human lung cells

Taisho Yamada, Seiichi Sato, Yuki Sotoyama et al. · Nature Immunology · 2021 · 239 citations · Full text

Life Sciences, Immunology, Infectious Diseases +15

New mutation causing hereditary hepatitis in the laboratory rat

Michihiro C. Yoshida, Ryuichi Masuda, Michihito Sasaki et al. · Journal of Heredity · 1987 · 219 citations

Medicine, Genetics, Pathology +9